SCHEMBL4596685

SCHEMBL4596685

COc1cc2c(c(-c3c(C)cccc3C)c1)OC(CC(Cc1ccccc1)NC(=O)O)C2

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.37
MAPT P10636 2/20 0.37
MEN1 O00255 1/20 0.37
APEX1 P27695 1/20 0.37
KMT2A Q03164 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
FFAR1 O14842 3/20 0.36
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 1/20 0.36
PPARG P37231 1/20 0.35
PPARA Q07869 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
ACHE P22303 1/20 0.35
PRKAB2 O43741 1/20 0.34
PRKAG1 P54619 1/20 0.34
PRKAA2 P54646 1/20 0.34
PRKAA1 Q13131 1/20 0.34
PRKAG3 Q9UGI9 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6374679 0.88 AQP1 (0.38) MAPTMEN1KMT2AL3MBTL1ALDH1A1
SCHEMBL4224650 0.81 MME (0.41) MAPTMEN1KMT2AL3MBTL1KDM4E
SCHEMBL6372229 0.79 PRKAB2 (0.38) MEN1KMT2AKDM4EALDH1A1PPARG
SCHEMBL6368102 0.79 AQP1 (0.40) MAPTKMT2AL3MBTL1ALDH1A1PPARG
SCHEMBL4230199 0.78 MTNR1A (0.39) POLBMAPTFFAR1PRKAB2PRKAG1
SCHEMBL4595205 0.78 AQP1 (0.37) MEN1KMT2APRKAB2PRKAG1PRKAA2
SCHEMBL4596692 0.77 LPAR1 (0.38) MAPTMEN1KMT2ATDP1FFAR1
SCHEMBL4596666 0.77 AQP1 (0.36) MAPTL3MBTL1ALDH1A1PRKAB2PRKAG1
SCHEMBL4233585 0.76 AQP1 (0.39) MAPTL3MBTL1ALDH1A1
SCHEMBL4596608 0.76 MMEL1 (0.39) MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1874750-A1 DIHYDROBENZOFURANYL ALKANAMINE DERIVATIVES AS 5HT2C AGONISTS Wyeth Incoporated (US) 2008-01-09 EP disclosed
US-20050261347-A1 Dihydrobenzofuranyl alkanamine derivatives and methods for using same WYETH (US) 2005-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050261347-A1 Dihydrobenzofuranyl alkanamine derivatives and methods for using same ADRA2A, HTR2A, ADRA1A POLB 3361/4885MAPT 2170/4885MEN1 3860/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.